Intuitive Surgical Files Q3 2024 10-Q

Ticker: ISRG · Form: 10-Q · Filed: Oct 18, 2024 · CIK: 1035267

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

Related Tickers: ISRG

TL;DR

ISRGs Q3 24 10-Q is in. Check financials.

AI Summary

Intuitive Surgical Inc. reported its third-quarter results for the period ending September 30, 2024. The company's filing indicates financial performance and operational details for this period, with specific financial figures and business segment information to be detailed within the full report.

Why It Matters

This filing provides investors and analysts with the latest financial performance data for Intuitive Surgical, a key player in robotic-assisted surgery.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing and does not inherently present new risks.

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240930, indicating the third quarter of 2024.

When was this 10-Q filed with the SEC?

The filing date (FILED AS OF DATE) is 20241018.

What is the company's Central Index Key (CIK)?

The Central Index Key for Intuitive Surgical Inc. is 0001035267.

What is the Standard Industrial Classification (SIC) code for Intuitive Surgical?

The SIC code is 3842, categorized under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

What is the company's state of incorporation?

Intuitive Surgical Inc. is incorporated in Delaware (DE).

Filing Stats: 4,591 words · 18 min read · ~15 pages · Grade level 7.8 · Accepted 2024-10-18 16:45:39

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited): Condensed Consolidated Balance Sheets as of September 30, 2024 , and December 31, 2023 3 Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2024 , and 2023 4 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 , and 2023 5 Notes to C ondensed C onsolidated F inancial S tatements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 48 Item 4.

Controls and Procedures

Controls and Procedures 48

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 49 Item 1A.

Risk Factors

Risk Factors 49 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 49 Item 3. Defaults Upon Senior Securities 49 Item 4. Mine Safety Disclosures 49 Item 5. Other Information 50 Item 6. Exhibits 51 Signature 52 2

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS INTUITIVE SURGICAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) in millions (except par values) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 2,413.3 $ 2,750.1 Short-term investments 1,818.4 2,473.1 Accounts receivable, net 1,153.0 1,130.2 Inventory 1,481.7 1,220.6 Prepaids and other current assets 349.2 314.0 Total current assets 7,215.6 7,888.0 Property, plant, and equipment, net 4,433.0 3,537.6 Long-term investments 4,079.8 2,120.0 Deferred tax assets 997.0 910.5 Intangible and other assets, net 669.7 636.7 Goodwill 348.3 348.7 Total assets $ 17,743.4 $ 15,441.5 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 218.7 $ 188.7 Accrued compensation and employee benefits 377.5 436.4 Deferred revenue 426.0 446.1 Other accrued liabilities 654.6 587.5 Total current liabilities 1,676.8 1,658.7 Other long-term liabilities 389.1 385.5 Total liabilities 2,065.9 2,044.2 Contingencies (Note 8) Stockholders' equity: Preferred stock, 2.5 shares authorized, $ 0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2024, and December 31, 2023 — — Common stock, 600.0 shares authorized, $ 0.001 par value, 356.2 shares and 352.3 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively 0.4 0.4 Additional paid-in capital 9,440.2 8,576.4 Retained earnings 6,129.8 4,743.0 Accumulated other comprehensive income (loss) 12.9 ( 12.2 ) Total Intuitive Surgical, Inc. stockholders' equity 15,583.3 13,307.6 Noncontrolling interest in joint venture 94.2 89.7 Total stockholders' equity 15,677.5 13,397.3 Total liabilities and stockholders' equity $ 17,743.4 $ 15,441.5 The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited). 3 INTUITIVE SURGICAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) T

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing